Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Test Your Knowledge Previous | All Articles This Week | Next
This article originally posted 17 December, 2010 and appeared in  Issue 552, Best of GLP-1, Genetics of Diabetes

TYK #552: Which one of the following statements about glucagon-like peptide 1 (GLP-1) is not true?

Which one of the following statements about glucagon-like peptide 1 (GLP-1) is not true?
Advertisement

1. It is a peptide that is constantly secreted at basal levels from the colon.

2. Its levels are decreased in people with Type 2 diabetes.

3. It enhances glucose-dependent insulin secretion.

4. It inhibits glucagon secretion.

5. It has a very short plasma half-life.
 

Click here for correct answer.

Related Articles

Diabetes Misdiagnosed in Asians, Native Hawaiians, and Other Pacific Islanders New Profile Program Discovers Those Predisposed to Type 2 Diabetes Why WBCs Attack Beta Cells in Type 1 Diabetes
Advertisement

 

Bookmark and Share | Print | Category | Home

This article originally posted 17 December, 2010 and appeared in  Issue 552, Best of GLP-1, Genetics of Diabetes

Past five issues: Diabetes Clinical Mastery Series Issue 85 | Issue 626 | Special Edition - Getting Patients on Track | Diabetes Clinical Mastery Series Issue 84 | Issue 625 |

 
Diabetes In Control Advertisers
 
 
Cast Your Vote
Now that once-weekly GLP-1 is available, which product are you recommending for your type 2 patients?

Navigate Diabetes In Control

Complications CE & CME Clinical Slides Drugs Affecting BG Safety Tools Test Your Knowledge Medications Polls Obesity Case Studies Jobs Interviews

Announcement:
 

Free Weekly Newsletter
Sign up here.

Free CE Available
CE Programs on diabetes

Search Articles On Diabetes In Control